
Terressa M. Boykin
Examiner (ID: 5881, Phone: (571)272-1069 , Office: P/1765 )
| Most Active Art Unit | 1765 |
| Art Unit(s) | 1764, 1207, 1711, 1796, 1503, 1765 |
| Total Applications | 4786 |
| Issued Applications | 4211 |
| Pending Applications | 203 |
| Abandoned Applications | 406 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18282936
[patent_doc_number] => 20230098408
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => SINGLE NUCLEIC ACID FOR REAL-TIME DETECTION FOR SNP ANALYSIS OF APOE GENE AND DETECTION METHOD USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/449140
[patent_app_country] => US
[patent_app_date] => 2021-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7616
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 272
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17449140
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/449140 | SINGLE NUCLEIC ACID FOR REAL-TIME DETECTION FOR SNP ANALYSIS OF APOE GENE AND DETECTION METHOD USING THE SAME | Sep 27, 2021 | Abandoned |
Array
(
[id] => 17444199
[patent_doc_number] => 20220064704
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-03
[patent_title] => METHODS OF PREPARING LARGE QUANTITIES OF SINGLE-STRANDED DNA (ssDNA)
[patent_app_type] => utility
[patent_app_number] => 17/410925
[patent_app_country] => US
[patent_app_date] => 2021-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17232
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17410925
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/410925 | METHODS OF PREPARING LARGE QUANTITIES OF SINGLE-STRANDED DNA (ssDNA) | Aug 23, 2021 | Abandoned |
Array
(
[id] => 17370385
[patent_doc_number] => 20220025437
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-27
[patent_title] => NOVEL METHOD OF COMBINED MOLECULAR CLAMPING AND ALLELE SPECIFIC qPCR TECHNOLOGY FOR KRAS G12C MUTATION DETECTION
[patent_app_type] => utility
[patent_app_number] => 17/386451
[patent_app_country] => US
[patent_app_date] => 2021-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8528
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17386451
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/386451 | NOVEL METHOD OF COMBINED MOLECULAR CLAMPING AND ALLELE SPECIFIC qPCR TECHNOLOGY FOR KRAS G12C MUTATION DETECTION | Jul 26, 2021 | Abandoned |
Array
(
[id] => 18565730
[patent_doc_number] => 20230256057
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-17
[patent_title] => TREATMENT OF IMMUNE DEPRESSION
[patent_app_type] => utility
[patent_app_number] => 18/015820
[patent_app_country] => US
[patent_app_date] => 2021-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37162
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18015820
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/015820 | TREATMENT OF IMMUNE DEPRESSION | Jul 12, 2021 | Pending |
Array
(
[id] => 18537810
[patent_doc_number] => 20230242911
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-03
[patent_title] => MicroRNA-TARGETED THERAPY FOR CARDIAC REPAIR
[patent_app_type] => utility
[patent_app_number] => 18/004877
[patent_app_country] => US
[patent_app_date] => 2021-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10309
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18004877
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/004877 | MicroRNA-TARGETED THERAPY FOR CARDIAC REPAIR | Jul 8, 2021 | Pending |
Array
(
[id] => 19641419
[patent_doc_number] => 20240415939
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-19
[patent_title] => COMPOSITIONS FOR GENOME EDITING AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/002767
[patent_app_country] => US
[patent_app_date] => 2021-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23245
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18002767
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/002767 | COMPOSITIONS FOR GENOME EDITING AND METHODS OF USE THEREOF | Jun 29, 2021 | Pending |
Array
(
[id] => 18550778
[patent_doc_number] => 20230248778
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-10
[patent_title] => THERAPEUTIC USE OF OF CELL-FREE FAT EXTRACT FOR PULMONARY DISEASES
[patent_app_type] => utility
[patent_app_number] => 18/001259
[patent_app_country] => US
[patent_app_date] => 2021-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8519
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18001259
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/001259 | THERAPEUTIC USE OF OF CELL-FREE FAT EXTRACT FOR PULMONARY DISEASES | Jun 10, 2021 | Pending |
Array
(
[id] => 18497713
[patent_doc_number] => 20230220391
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-13
[patent_title] => CILP-1 Inhibitors for Use in the Treatment of Dilated Cardiomyopathies
[patent_app_type] => utility
[patent_app_number] => 18/009018
[patent_app_country] => US
[patent_app_date] => 2021-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14054
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18009018
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/009018 | CILP-1 Inhibitors for Use in the Treatment of Dilated Cardiomyopathies | Jun 8, 2021 | Pending |
Array
(
[id] => 18420557
[patent_doc_number] => 20230175019
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-08
[patent_title] => SCALABLE TRIO GUIDE RNA APPROACH FOR INTEGRATION OF LARGE DONOR DNA
[patent_app_type] => utility
[patent_app_number] => 17/927454
[patent_app_country] => US
[patent_app_date] => 2021-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12849
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17927454
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/927454 | SCALABLE TRIO GUIDE RNA APPROACH FOR INTEGRATION OF LARGE DONOR DNA | May 27, 2021 | Pending |
Array
(
[id] => 18436456
[patent_doc_number] => 20230183750
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-15
[patent_title] => HDR ENHANCERS
[patent_app_type] => utility
[patent_app_number] => 17/999307
[patent_app_country] => US
[patent_app_date] => 2021-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7287
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17999307
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/999307 | HDR ENHANCERS | May 19, 2021 | Pending |
Array
(
[id] => 18417733
[patent_doc_number] => 20230172189
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-08
[patent_title] => Methods for Extending the Shelf-life of Stored Donor Blood and/or Red Blood Cells and Treated Red Blood Cell Compositions Produced Thereby
[patent_app_type] => utility
[patent_app_number] => 17/919364
[patent_app_country] => US
[patent_app_date] => 2021-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6267
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17919364
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/919364 | Methods for Extending the Shelf-life of Stored Donor Blood and/or Red Blood Cells and Treated Red Blood Cell Compositions Produced Thereby | Apr 25, 2021 | Pending |
Array
(
[id] => 18510019
[patent_doc_number] => 20230226114
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-20
[patent_title] => COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 17/916166
[patent_app_country] => US
[patent_app_date] => 2021-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7976
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17916166
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/916166 | COMPOSITION | Apr 1, 2021 | Pending |
Array
(
[id] => 18333994
[patent_doc_number] => 20230125942
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-27
[patent_title] => METHOD FOR EDITING TARGET RNA
[patent_app_type] => utility
[patent_app_number] => 17/915232
[patent_app_country] => US
[patent_app_date] => 2021-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18108
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 115
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17915232
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/915232 | METHOD FOR EDITING TARGET RNA | Mar 30, 2021 | Pending |
Array
(
[id] => 18497665
[patent_doc_number] => 20230220331
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-13
[patent_title] => TEMPORARY TREATMENT MEDIUM, TREATMENT KIT, EMBRYOGENESIS ARREST INHIBITOR, EMBRYOGENESIS ARREST INHIBITORY METHOD, DEVELOPMENTAL ENGINEERING PRODUCT PREPARATION METHOD, TRANSPLANTATION METHOD, THERAPEUTIC METHOD, AND DEVELOPMENTAL ENGINEERING PRODUCT
[patent_app_type] => utility
[patent_app_number] => 17/914323
[patent_app_country] => US
[patent_app_date] => 2021-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18931
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17914323
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/914323 | TEMPORARY TREATMENT MEDIUM, TREATMENT KIT, EMBRYOGENESIS ARREST INHIBITOR, EMBRYOGENESIS ARREST INHIBITORY METHOD, DEVELOPMENTAL ENGINEERING PRODUCT PREPARATION METHOD, TRANSPLANTATION METHOD, THERAPEUTIC METHOD, AND DEVELOPMENTAL ENGINEERING PRODUCT | Mar 22, 2021 | Pending |
Array
(
[id] => 18417719
[patent_doc_number] => 20230172175
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-08
[patent_title] => RECOMBINANT PROTEIN PRODUCTION IN INSECTS
[patent_app_type] => utility
[patent_app_number] => 17/911930
[patent_app_country] => US
[patent_app_date] => 2021-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11816
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17911930
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/911930 | RECOMBINANT PROTEIN PRODUCTION IN INSECTS | Mar 14, 2021 | Pending |
Array
(
[id] => 18242063
[patent_doc_number] => 20230074374
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-09
[patent_title] => METHODS OF MANUFACTURING EXTRACELLULAR MATRIX USING ASPARTYL ALANYL DIKETOPIPERAZINE (DA-DKP)
[patent_app_type] => utility
[patent_app_number] => 17/800134
[patent_app_country] => US
[patent_app_date] => 2021-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13955
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17800134
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/800134 | METHODS OF MANUFACTURING EXTRACELLULAR MATRIX USING ASPARTYL ALANYL DIKETOPIPERAZINE (DA-DKP) | Feb 15, 2021 | Abandoned |
Array
(
[id] => 18264621
[patent_doc_number] => 20230085863
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-23
[patent_title] => TELOMERE LENGTH MODULATION USING FIBROBLASTS
[patent_app_type] => utility
[patent_app_number] => 17/904180
[patent_app_country] => US
[patent_app_date] => 2021-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12936
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17904180
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/904180 | TELOMERE LENGTH MODULATION USING FIBROBLASTS | Feb 15, 2021 | Pending |
Array
(
[id] => 17034983
[patent_doc_number] => 20210251941
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-19
[patent_title] => METHODS OF TREATING HYPERTRIGLYCERIDEMIA
[patent_app_type] => utility
[patent_app_number] => 17/153494
[patent_app_country] => US
[patent_app_date] => 2021-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9598
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17153494
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/153494 | METHODS OF TREATING HYPERTRIGLYCERIDEMIA | Jan 19, 2021 | Abandoned |
Array
(
[id] => 18108172
[patent_doc_number] => 20230001052
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-05
[patent_title] => AN ACELLULAR NERVE GRAFT
[patent_app_type] => utility
[patent_app_number] => 17/779783
[patent_app_country] => US
[patent_app_date] => 2020-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5917
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17779783
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/779783 | AN ACELLULAR NERVE GRAFT | Nov 26, 2020 | Pending |
Array
(
[id] => 17563525
[patent_doc_number] => 20220127674
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-28
[patent_title] => METHODS FOR DETECTING CIRCULATING STROMAL CELLS
[patent_app_type] => utility
[patent_app_number] => 17/082489
[patent_app_country] => US
[patent_app_date] => 2020-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9124
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 177
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17082489
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/082489 | METHODS FOR DETECTING CIRCULATING STROMAL CELLS | Oct 27, 2020 | Abandoned |